15.06.08 Foster® - New in the Austrian Market

---

Foster®, a new in-house developed product, is now fully reimbursed available  in the Austrian market since May 1st, 2008.

Due to the synergism of both agents in the extra-fine combination of Formoterol and Beclometason and its quick onset of action, Foster® is used in the treatment of Asthma.

Besides Austria, it is currently marketed in Germany, France, England, the Netherlands, Slovenia, Slovakia, Hungary and Spain. More launches to follow soon.

 

 

---